As of 2025-10-30, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.57 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.53 USD, the upside of Design Therapeutics Inc is -185.36%.
Based on its market price of 6.53 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 185.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.57 - -5.57 | -5.57 | -185.36% |
| P/E | (16.21) - (16.57) | (16.14) | -347.1% |
| DDM - Stable | (10.78) - (37.23) | (24.01) | -467.6% |
| DDM - Multi | (7.90) - (21.40) | (11.56) | -277.1% |
| Market Cap (mil) | 371.88 |
| Beta | 0.92 |
| Outstanding shares (mil) | 56.95 |
| Enterprise Value (mil) | 352.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.97% |
| Cost of Debt | 5.00% |
| WACC | 6.43% |